{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:56:09Z","timestamp":1789052169880,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.iac.2010.02.003","type":"journal-article","created":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T08:29:33Z","timestamp":1274344173000},"page":"249-260","source":"Crossref","is-referenced-by-count":15,"title":["Gene Therapy for Adenosine Deaminase Deficiency"],"prefix":"10.1016","volume":"30","author":[{"given":"Barbara","family":"Cappelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.iac.2010.02.003_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM199508173330707","article-title":"The primary immunodeficiencies","volume":"333","author":"Rosen","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.iac.2010.02.003_bib2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","article-title":"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee","volume":"120","author":"Geha","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2010.02.003_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.15.1.93","article-title":"Naturally occurring primary deficiencies of the immune system","volume":"15","author":"Fischer","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.iac.2010.02.003_bib4","series-title":"Primary immunodeficiency diseases","first-page":"169","article-title":"Immunodeficiency due to defects of purine metabolism","author":"Hirschorn","year":"2006"},{"issue":"6","key":"10.1016\/j.iac.2010.02.003_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/ACI.0b013e3283327da5","article-title":"New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy","volume":"9","author":"Sauer","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2010.02.003_bib6","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1182\/blood-2007-05-092429","article-title":"Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients","volume":"111","author":"Cassani","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.iac.2010.02.003_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/j.1460-2075.1985.tb03648.x","article-title":"Adenosine deaminase: characterization and expression of a gene with a remarkable promoter","volume":"4","author":"Valerio","year":"1985","journal-title":"EMBO J"},{"issue":"7786","key":"10.1016\/j.iac.2010.02.003_bib8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine deaminase deficiency in two patients with severely impaired cellular immunity","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.iac.2010.02.003_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/302054","article-title":"Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles","volume":"63","author":"Arredondo-Vega","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"16","key":"10.1016\/j.iac.2010.02.003_bib10","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1073\/pnas.87.16.6171","article-title":"Hot spot mutations in adenosine deaminase deficiency","volume":"87","author":"Hirschhorn","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.iac.2010.02.003_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2006.12.009","article-title":"Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006)","volume":"123","author":"Booth","year":"2007","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"9357","key":"10.1016\/j.iac.2010.02.003_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968\u201399","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.iac.2010.02.003_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.iac.2010.02.003_bib14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jama.295.5.508","article-title":"Bone marrow transplantation for severe combined immune deficiency","volume":"295","author":"Grunebaum","year":"2006","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.iac.2010.02.003_bib15","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How I treat ADA deficiency","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2010.02.003_bib16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI110389","article-title":"Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients","volume":"68","author":"Hirschhorn","year":"1981","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.iac.2010.02.003_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ymthe.2006.06.007","article-title":"Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild reconditioning","volume":"14","author":"Gaspar","year":"2006","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.iac.2010.02.003_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mpd.2001.115023","article-title":"Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency","volume":"139","author":"Rogers","year":"2001","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.iac.2010.02.003_bib19","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2006-07-034678","article-title":"Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications","volume":"109","author":"Honig","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.iac.2010.02.003_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1705946","article-title":"Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies","volume":"41","author":"Diaz de Heredia","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.iac.2010.02.003_bib21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jpeds.2009.07.049","article-title":"Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis","volume":"155","author":"Railey","year":"2009","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.iac.2010.02.003_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"N Engl J Med"},{"issue":"3 Pt 2","key":"10.1016\/j.iac.2010.02.003_bib23","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1016\/S0090-1229(95)90306-2","article-title":"PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years","volume":"76","author":"Hershfield","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.iac.2010.02.003_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.iac.2008.02.001","article-title":"Gene therapy for primary immunodeficiencies","volume":"28","author":"Thrasher","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.iac.2010.02.003_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMe0809614","article-title":"Gene therapy fulfilling its promise","volume":"360","author":"Kohn","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.iac.2010.02.003_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.iac.2010.02.003_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00130832-200312000-00007","article-title":"Gene therapy for adenosine deaminase deficiency","volume":"3","author":"Aiuti","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2010.02.003_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm0798-775","article-title":"T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates","volume":"4","author":"Kohn","year":"1998","journal-title":"Nat Med"},{"issue":"5235","key":"10.1016\/j.iac.2010.02.003_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.iac.2010.02.003_bib30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.iac.2010.02.003_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm0502-423","article-title":"Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement","volume":"8","author":"Aiuti","year":"2002","journal-title":"Nat Med"},{"issue":"5466","key":"10.1016\/j.iac.2010.02.003_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.iac.2010.02.003_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MOH.0b013e328302c807","article-title":"Recent advances in gene therapy for severe congenital immunodeficiency diseases","volume":"15","author":"Sokolic","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.iac.2010.02.003_bib34","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.iac.2010.02.003_bib35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2006-06-031476","article-title":"Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report","volume":"109","author":"Engel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.iac.2010.02.003_bib36","doi-asserted-by":"crossref","first-page":"S418","DOI":"10.1016\/j.ymthe.2006.08.1190","article-title":"Stem cell gene therapy with no pre-conditioning for the ADA-deficiency patients leads to generalized detoxification and delayed, but steady hematological reconstitution","volume":"13","author":"Otsu","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.iac.2010.02.003_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/asheducation-2009.1.682","article-title":"Ten years of gene therapy for primary immunedeficiencies","author":"Aiuti","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5644","key":"10.1016\/j.iac.2010.02.003_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.iac.2010.02.003_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.iac.2010.02.003_bib40","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1172\/JCI31666","article-title":"Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy","volume":"117","author":"Aiuti","year":"2007","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.iac.2010.02.003_bib41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nbt1367","article-title":"Genetic therapies against HIV","volume":"25","author":"Rossi","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"5954","key":"10.1016\/j.iac.2010.02.003_bib42","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.iac.2010.02.003_bib43","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2009.31","article-title":"Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models","volume":"17","author":"Marangoni","year":"2009","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/j.iac.2010.02.003_bib44","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2006-05-023507","article-title":"Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects","volume":"108","author":"Mortellaro","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2010.02.003_bib45","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ymthe.2006.02.013","article-title":"In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency","volume":"13","author":"Carbonaro","year":"2006","journal-title":"Mol Ther"},{"issue":"7042","key":"10.1016\/j.iac.2010.02.003_bib46","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature03556","article-title":"Highly efficient endogenous human gene correction using designed zinc-finger nucleases","volume":"435","author":"Urnov","year":"2005","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.iac.2010.02.003_bib47","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat Biotechnol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856110000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856110000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:39:58Z","timestamp":1559108398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856110000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0889856110000214"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2010.02.003","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}